226 related articles for article (PubMed ID: 30866135)
1. Intralesional therapy for the treatment of keratoacanthoma.
Kiss N; Avci P; Bánvölgyi A; Lőrincz K; Szakonyi J; Gyöngyösi N; Fésűs L; Lee G; Wikonkál N
Dermatol Ther; 2019 May; 32(3):e12872. PubMed ID: 30866135
[TBL] [Abstract][Full Text] [Related]
2. Treatment of Solitary Keratoacanthoma of the Nose With Intralesional Methotrexate and Review of the Literature.
Doerfler L; Hanke CW
J Drugs Dermatol; 2019 Jul; 18(7):693-696. PubMed ID: 31334929
[TBL] [Abstract][Full Text] [Related]
3. Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons.
Chitwood K; Etzkorn J; Cohen G
Dermatol Surg; 2013 Sep; 39(9):1306-16. PubMed ID: 23915332
[TBL] [Abstract][Full Text] [Related]
4. Is the first-line treatment of keratoacanthomas surgical excision or injection of intralesional chemotherapy?
Hoegler KM; Schleichert RA
J Am Acad Dermatol; 2020 Nov; 83(5):1542-1543. PubMed ID: 32622139
[No Abstract] [Full Text] [Related]
5. Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer: A Systematic Review.
Maghfour J; Kuraitis D; Murina A
J Drugs Dermatol; 2021 Feb; 20(2):192-198. PubMed ID: 33538569
[TBL] [Abstract][Full Text] [Related]
6. Management of Keratoacanthoma: 157 Tumors Treated With Surgery or Intralesional Methotrexate.
Moss M; Weber E; Hoverson K; Montemarano AD
Dermatol Surg; 2019 Jul; 45(7):877-883. PubMed ID: 30608293
[TBL] [Abstract][Full Text] [Related]
7. Multiple keratoacanthomas occurring in surgical margins and de novo treated with intralesional methotrexate.
Veerula VL; Ezra N; Aouthmany M; Graham TA; Wolverton SE; Somani AK
Cutis; 2016 Dec; 98(6):E12-E15. PubMed ID: 28099546
[TBL] [Abstract][Full Text] [Related]
8. Intralesional agents in the management of cutaneous malignancy: a review.
Good LM; Miller MD; High WA
J Am Acad Dermatol; 2011 Feb; 64(2):413-22. PubMed ID: 20334952
[TBL] [Abstract][Full Text] [Related]
9. Debulking followed by intralesional 5-fluorouracil for the treatment of cutaneous squamous cell carcinoma and keratoacanthoma: A retrospective analysis.
Hamad J; Jolly PS
Dermatol Ther; 2021 Nov; 34(6):e15139. PubMed ID: 34549487
[TBL] [Abstract][Full Text] [Related]
10. Eruptive squamous atypia (also known as eruptive keratoacanthoma): Definition of the disease entity and successful management via intralesional 5-fluorouracil.
Que SKT; Compton LA; Schmults CD
J Am Acad Dermatol; 2019 Jul; 81(1):111-122. PubMed ID: 31103317
[TBL] [Abstract][Full Text] [Related]
11. [Intralesional methotrexate injection: an effective time and cost saving therapy alternative in keratoacanthomas that are difficult to treat surgically].
Remling R; Mempel M; Schnopp N; Abeck D; Ring J
Hautarzt; 2000 Aug; 51(8):612-4. PubMed ID: 10997318
[TBL] [Abstract][Full Text] [Related]
12. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature.
Annest NM; VanBeek MJ; Arpey CJ; Whitaker DC
J Am Acad Dermatol; 2007 Jun; 56(6):989-93. PubMed ID: 17504715
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of keratoacanthoma with intralesional methotrexate injections].
Richard MA; Gachon J; Choux R; Laurans R; Folchetti G; Grob JJ
Ann Dermatol Venereol; 2000 Dec; 127(12):1097. PubMed ID: 11173689
[No Abstract] [Full Text] [Related]
14. Intralesional methotrexate as non-surgical therapy for giant keratoacanthoma on the nose.
Sayan A; Taibjee S; Ilankovan V
Br J Oral Maxillofac Surg; 2024 Feb; 62(2):203-205. PubMed ID: 38267280
[TBL] [Abstract][Full Text] [Related]
15. [Intralesional infusion of methotrexate as neoadjuvant therapy improves the cosmetic and functional results of surgery to treat keratoacanthoma: results of a randomized trial].
Martorell-Calatayud A; Requena C; Nagore E; Sanmartín O; Serra-Guillén C; Botella-Estrada R; Sanz-Motilva V; Llombart B; Alcañiz-Moscardo A; Guillén-Barona C
Actas Dermosifiliogr; 2011 Oct; 102(8):605-15. PubMed ID: 21742301
[TBL] [Abstract][Full Text] [Related]
16. Giant keratoacanthoma-type low-grade squamous cell carcinoma of the upper lip: Response to intralesional interferon alpha-2B.
Anadolu R; Akay BN; Bodamyali P; Akyol A
J Dermatolog Treat; 2011 Aug; 22(4):239-40. PubMed ID: 20666675
[No Abstract] [Full Text] [Related]
17. Intralesional chemotherapy for nonmelanoma skin cancer: a practical review.
Kirby JS; Miller CJ
J Am Acad Dermatol; 2010 Oct; 63(4):689-702. PubMed ID: 20605654
[TBL] [Abstract][Full Text] [Related]
18. Intralesional methotrexate in solitary keratoacanthoma.
Cuesta-Romero C; de Grado-Peña J
Arch Dermatol; 1998 Apr; 134(4):513-4. PubMed ID: 9580539
[No Abstract] [Full Text] [Related]
19. Dilute Intralesional 5-Fluorouracil for the Treatment of Squamous Cell Carcinomas and Keratoacanthomas: A Case Series.
Marka A; Rodgers D; Zelaya Castillo L; Hoyt B; Chapman M; Carter J
J Drugs Dermatol; 2023 May; 22(5):507-508. PubMed ID: 37133471
[TBL] [Abstract][Full Text] [Related]
20. Successful non-operative treatment of eruptive keratoacanthomas refractory to excision.
Seger EW; Tarantino IS; Neill BC; Wang T
Dermatol Online J; 2020 Mar; 26(3):. PubMed ID: 32609455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
